Q1 2024 EPS Estimates for bluebird bio, Inc. (NASDAQ:BLUE) Reduced by Analyst
bluebird bio, Inc. (NASDAQ:BLUE – Free Report) – Analysts at Leerink Partnrs decreased their Q1 2024 earnings per share estimates for shares of bluebird bio in a research report issued on Tuesday, March 26th. Leerink Partnrs analyst M. Foroohar now anticipates that the biotechnology company will post earnings per share of ($0.29) for the quarter, […]
More Stories
How to Verify the Security Compliance of Your Third-Party Billing Vendors
When you outsource your billing to a third party, it may give the impression that the associated risk is also...
10+ Best SaaS Marketing Agencies That You Need in 2026
Most B2B SaaS companies still hire partners the same way they did years ago and wonder why their growth graphs...
Top 10 Six Sigma Tools That Will Grow Your Business in 2026
Every company faces the same problems while running its business: repeated mistakes, hidden waste, and insufficient processes that don’t deliver...
Ukraine Reports Crash of One of Its F-16s, Pilot Safe
By Victoria Friedman The Armed Forces of Ukraine said one of its F-16 fighter jets had crashed, and that the...
US Gas Prices Remain Elevated Amid Ongoing Middle East Tensions US Gas Prices Remain Elevated Amid Ongoing Middle East Tensions
By Naveen Athrappully Gasoline prices in the United States continue to remain high at over $4 per gallon as the...
Spain’s Ceuta Overwhelmed as Nearly 60,000 Illegal Immigrants Cross From Morocco in a Day
By Owen Evans Ceuta was overwhelmed overnight as the Spanish North African exclave faced a fresh wave of nearly 60,000...